The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma

Ciaran O'Neill, Peter G. Gibson, Liam G. Heaney, John W. Upham, Ian A. Yang, Paul N. Reynolds, Sandra Hodge, Christine R. Jenkins, Matthew Peters, Guy B. Marks, Alan L. James, Jodie L. Simpson

Source: Eur Respir J, 57 (2) 2002436; 10.1183/13993003.02436-2020
Journal Issue: February
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ciaran O'Neill, Peter G. Gibson, Liam G. Heaney, John W. Upham, Ian A. Yang, Paul N. Reynolds, Sandra Hodge, Christine R. Jenkins, Matthew Peters, Guy B. Marks, Alan L. James, Jodie L. Simpson. The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma. Eur Respir J, 57 (2) 2002436; 10.1183/13993003.02436-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ceruloplasmine efficacy in patients with asthma exacerbations
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011

An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Long-term azithromycin therapy in severe COPD with repeated exacerbations
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010


Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017


Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Budesonide/formoterol added to tiotropium improves exacerbations and exacerbation-related antibiotic use in patients with COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

The direct costs of exacerbations in COPD and the effect of cilomilast treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 245s
Year: 2002

Efficacy and safety of various antimicrobial regimens in the treatment of acute exacerbations of chronic bronchitis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003

Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB)
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003


Evaluating the efficacy of omalizumab in severe persistent asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019



Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019



Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Efficacy and safety of adding erdosteine in acute exacerbations of COPD (AECOPD): a comparative analysis with the standard treatment
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


Macrolides in the prevention of COPD exacerbations
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012


Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


Perceived bronchodilator efficacy during severe asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006